Phone: (011) 7541-421, 3409-301, 3409-335, 6547-293, 3409-310
E-mail: Standards sales: prodaja@iss.rs Education: iss-edukacija@iss.rs Information about standards: infocentar@iss.rs
Stevana Brakusa 2, 11030 Beograd
Main menu

SRPS EN ISO 22442-3:2011

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007)

Sep 30, 2011

General information

60.60     Sep 30, 2011

ISS

Z076

European Norm

11.100.20  

English  

From plan 2011

Buying

Published

Language in which you want to receive the document.

Scope

ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.

Related directives

NOTE: If the word "harmonized" (marked in green) is not found in the field with the name of the directive, it means that the European standard is not cited in the OJEU.

93/42/EEC

Medical devices

Harmonized

Life cycle

NOW

PUBLISHED
SRPS EN ISO 22442-3:2011
60.60 Standard published
Sep 30, 2011

REVISED BY

PROJECT
prSRPS EN ISO 22442-3:2024

Related project

Adopted from EN ISO 22442-3:2007

Adopted from ISO 22442-3:2007 IDENTICAL